Cohort Study in Fujian Province

Fujian Cohort Study of cARdiomEtabolic Disease and Comorbidity(Fu-CARE)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06102187

Enrollment

150000

Registered

2023-10-26

Start date

2017-01-01

Completion date

2026-12-31

Last updated

2023-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Disease

Keywords

Cardiovascular and metabolic disease comorbidity

Brief summary

In this study, Chinese residents aged 35 to 75 years old were recruited from Fujian Province. Physical examination, questionnaire survey and biological sample collection were performed at baseline, and at least 4 years of follow-up were conducted. Information on newly discovered cardiovascular metabolic illnesses and comorbidities was collected during follow-up, and repeated surveys similar to baseline were conducted. To explore the relationship between environment, diet and lifestyle and the risk of cardiovascular metabolic diseases and concomitant disorders.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

35 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* Aged 35-75, having lived in Fuzhou, Putian, Quanzhou, Nanping, Xiamen, Zhangzhou, Longyan, Sanming, or Ningde in Fujian Province for more than 6 months.

Exclusion criteria

* Anyone diagnosed with coronary heart disease, stroke, or cancer. * Anyone with a severe disability who is unable to participate in the study.

Design outcomes

Primary

Measure	Time frame	Description
Coronary Disease	5 years	It is a form of myocardial ischemia (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. At the follow-up, the outcomes of coronary events were acquired. Coronary CTA examination and coronary angiography were the primary measuring modalities.

Secondary

Measure	Time frame	Description
other metabolic diseases	5 years	Including hypertension, stroke, diabetes, impaired glucose tolerance, obesity, cancer, chronic obstructive pulmonary disease and chronic kidney disease. These disorders were diagnosed using international standards, and the necessary information was gathered during face-to-face follow-up.

Countries

China

Contacts

Primary ContactKaiyang Lin

lky7411@sina.com+8613559355708

Outcome results